Skip to main content

CareDx, Inc.

corporate_fare Company Profile

CareDx, Inc.

CDNA·NASDAQ·Industrial Applications And Services·CIK 0001217234

CareDx is a precision medicine company focused on improving outcomes for transplant patients and advancing organ health. The company provides integrated solutions designed to empower clinicians and improve patient outcomes. These solutions include non-invasive molecular testing for heart, kidney, and lung transplants, laboratory products, digital health technologies, and patient solutions that support care before and after transplant. CareDx is the leading provider of genomics-based information for transplant patients. The company's headquarters is in Brisbane, California, with other primary operations in Omaha, Nebraska, and Stockholm, Sweden. CareDx was originally incorporated in Delaware in December 1998 as Hippocratic Engineering, Inc., changing its name to BioCardia, Inc. in April 1999, Expression Diagnostics, Inc. in June 2002, XDx, Inc. in July 2007, and finally CareDx, Inc. in March 2014. As of December 31, 2025, substantially all of CareDx's revenues came from the United States and Europe, and substantially all of its assets and operations were located in the United States and Sweden. The company is organized and operates as a single reportable segment.

CareDx, Inc. (NASDAQ:CDNA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 20 items for CDNA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for CDNA spans 10-Q, 8-K, 8-K/A, 10-K.

Recent high-impact activity:

  • CareDx 10-Q Details $250M Cash, Naveris Deal Accounting and New Insider Selling Plans
  • CareDx Beats on Q3 Revenue of $139M and Lifts FY26 Revenue Guidance to $520M-$530M
  • CareDx Posts 70c Adjusted EPS for Third Quarter
  • CareDx Files Naveris Financials: Going Concern Warning in Acquired Business
  • CareDx Raises 2026 Guidance to $490–$500M, Unveils New Transplant Assay Data

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$379.81M
Net Income
-$21.35M
Diluted EPS
-$0.40
Op. Cash Flow
$42.03M
Operating Income
-$30.78M
Cash & Equivalents
$65.43M
Debt / Equity
0.00×
Net Margin
-5.6%
Shares Outstanding
50.92M sh
Source: 10-K · filed 2026-02-25 · accession 0001217234-26-000018

Short Interest & Short Volume

5.28 days to cover

FINRA reported short interest of 7,187,391 shares in CDNA as of the October 30, 2026 settlement, a 7.0% increase from the prior period — about 5.3 days to cover at its recent average daily volume. On November 20, 2026, 34.5% of CDNA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)7,187,391 shares as of October 30, 2026
Change vs prior period▲ 7.0%
Days to cover5.28 at avg daily volume of 1,360,855
Daily short volume (FINRA facilities)34.5% of 297,462 shares on November 20, 2026
5-day average short volume34.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$69.79 -0.30% today
52-week range · as of 2026-10-29 $14.22 – $73.43
Market cap
$3.68B
Volume
782K (0.6× avg)
3-mo avg 1.2M
Live data · 2026-11-22 01:14 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CDNA - Latest Insights

CDNA
Oct 29, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $78.00
Real-time Price: $69.79 info
Change: -$8.21 (-11%) info
Market Cap: $3.678B info
CDNA
Oct 29, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $80.04
Real-time Price: $69.79 info
Change: -$10.25 (-13%) info
Market Cap: $3.678B info
CDNA
Oct 29, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $71.49
Real-time Price: $69.79 info
Change: -$1.70 (-2%) info
Market Cap: $3.678B info
CDNA
Sep 16, 2026, 4:06 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $53.55
Real-time Price: $69.79 info
Change: +$16.24 (+30%) info
Market Cap: $3.678B info
CDNA
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $44.99
Real-time Price: $69.79 info
Change: +$24.80 (+55%) info
Market Cap: $3.678B info
CDNA
Aug 01, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $42.99
Real-time Price: $69.79 info
Change: +$26.80 (+62%) info
Market Cap: $3.678B info
CDNA
Jul 30, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $41.00
Real-time Price: $69.79 info
Change: +$28.79 (+70%) info
Market Cap: $3.678B info
CDNA
Jul 30, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $41.00
Real-time Price: $69.79 info
Change: +$28.79 (+70%) info
Market Cap: $3.678B info
CDNA
Jul 16, 2026, 11:07 PM EDT
Source: dpa-AFX
Importance Score:
9
Price at Filing: $39.70
Real-time Price: $69.79 info
Change: +$30.09 (+76%) info
Market Cap: $3.678B info
CDNA
Jul 01, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $29.25
Real-time Price: $69.79 info
Change: +$40.54 (+139%) info
Market Cap: $3.678B info
CDNA
Jul 01, 2026, 2:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $28.50
Real-time Price: $69.79 info
Change: +$41.29 (+145%) info
Market Cap: $3.678B info
CDNA
Jun 01, 2026, 1:38 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $22.69
Real-time Price: $69.79 info
Change: +$47.10 (+208%) info
Market Cap: $3.678B info
CDNA
Apr 28, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $20.18
Real-time Price: $69.79 info
Change: +$49.61 (+246%) info
Market Cap: $3.678B info
CDNA
Apr 28, 2026, 4:12 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $21.85
Real-time Price: $69.79 info
Change: +$47.94 (+219%) info
Market Cap: $3.678B info
CDNA
Apr 28, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $20.58
Real-time Price: $69.79 info
Change: +$49.21 (+239%) info
Market Cap: $3.678B info
CDNA
Apr 16, 2026, 6:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.91
Real-time Price: $69.79 info
Change: +$51.88 (+290%) info
Market Cap: $3.678B info
CDNA
Apr 15, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $18.33
Real-time Price: $69.79 info
Change: +$51.46 (+281%) info
Market Cap: $3.678B info
CDNA
Feb 25, 2026, 4:10 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $18.46
Real-time Price: $69.79 info
Change: +$51.33 (+278%) info
Market Cap: $3.678B info
CDNA
Feb 24, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $18.94
Real-time Price: $69.79 info
Change: +$50.85 (+268%) info
Market Cap: $3.678B info
CDNA
Jan 12, 2026, 7:08 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.68
Real-time Price: $69.79 info
Change: +$52.11 (+295%) info
Market Cap: $3.678B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets